<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Spectrins are a family of cytoskeletal proteins that organize and link membranes to subcellular motors and filaments </plain></SENT>
<SENT sid="1" pm="."><plain>Although traditionally divided into erythroid and non-erythroid forms, the discovery of new spectrin isoforms in various tissues indicates that their distribution is not yet fully characterized </plain></SENT>
<SENT sid="2" pm="."><plain>To our knowledge, there is no comprehensive analysis of spectrins in lymphoid <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Using <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> microarrays of paraffin blocks, we immunohistochemically studied 10 lymph nodes with reactive <z:mp ids='MP_0000688'>lymphoid hyperplasia</z:mp> and 94 lymph nodes involved by B-cell malignant <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Expression of spectrins alphaI, alphaII, betaI, betaII, and betaIII was scored using a 20% cutoff for positive immunoperoxidase staining </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> spectrin isoforms, except erythroid-specific alphaI spectrin, were detected in lymph nodes with reactive <z:mp ids='MP_0000688'>lymphoid hyperplasia</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>In contrast, various spectrins were lost in particular B-cell malignant <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Based on the absence of staining for one or more spectrin isoforms in at least 50% of cases, we identified three patterns: (1) loss of alphaII and betaII in follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, grades 2/3 and 3/3; nodular lymphocyte predominance Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>; nodular <z:mp ids='MP_0000612'>sclerosis</z:mp> Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>; (2) loss of betaI only in Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo>; and (3) loss of alphaII and betaI in mixed cellularity Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>In contrast, follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, grade 1/3 and diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> retained spectrin in 67-100% of cases </plain></SENT>
<SENT sid="9" pm="."><plain>The other <z:hpo ids='HP_0002665'>lymphoma</z:hpo> subtypes retained spectrin in greater than 50% of cases </plain></SENT>
<SENT sid="10" pm="."><plain>We identified the loss of particular spectrin isoforms in B-cell malignant <z:hpo ids='HP_0002665'>lymphomas</z:hpo> that have a nodular growth pattern and/or are believed to arise from germinal center B-cells, that is follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, grades 2/3 and 3/3; Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo>; nodular <z:mp ids='MP_0000612'>sclerosis</z:mp> Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>; mixed cellularity Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>; and nodular lymphocyte predominance Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>The absence of particular spectrin isoforms may correlate with transformation or aggressive biologic behavior for some <z:hpo ids='HP_0002665'>lymphoma</z:hpo> subtypes </plain></SENT>
</text></document>